RS53495B2 - Postupak za sintezu 7,8-dimetoksi-1,3-dihidro-2h-3-benzazepin-2-ona i, njegova primena u sintezi ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom - Google Patents

Postupak za sintezu 7,8-dimetoksi-1,3-dihidro-2h-3-benzazepin-2-ona i, njegova primena u sintezi ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom

Info

Publication number
RS53495B2
RS53495B2 RS20140439A RSP20140439A RS53495B2 RS 53495 B2 RS53495 B2 RS 53495B2 RS 20140439 A RS20140439 A RS 20140439A RS P20140439 A RSP20140439 A RS P20140439A RS 53495 B2 RS53495 B2 RS 53495B2
Authority
RS
Serbia
Prior art keywords
synthesis
dihidro
ivabradine
benzazepin
dimethoxy
Prior art date
Application number
RS20140439A
Other languages
English (en)
Inventor
Jean-Michel Lerestif
Jean-Pierre Lecouve
Daniel Brigot
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40347797&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS53495(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of RS53495B1 publication Critical patent/RS53495B1/sr
Publication of RS53495B2 publication Critical patent/RS53495B2/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
RS20140439A 2008-06-20 2009-06-19 Postupak za sintezu 7,8-dimetoksi-1,3-dihidro-2h-3-benzazepin-2-ona i, njegova primena u sintezi ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom RS53495B2 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0803452A FR2932800B1 (fr) 2008-06-20 2008-06-20 Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
EP09290466.3A EP2135861B2 (fr) 2008-06-20 2009-06-19 Procédé de synthèse de la 7,8-diméthoxy-1,3-dihydro-2H-3-benzazépin-2-one, et son application à la synthèse de l'ivabradine et de ses sels d'addition avec un acide pharmaceutiquement acceptable

Publications (2)

Publication Number Publication Date
RS53495B1 RS53495B1 (sr) 2015-02-27
RS53495B2 true RS53495B2 (sr) 2021-02-26

Family

ID=40347797

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20140439A RS53495B2 (sr) 2008-06-20 2009-06-19 Postupak za sintezu 7,8-dimetoksi-1,3-dihidro-2h-3-benzazepin-2-ona i, njegova primena u sintezi ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom

Country Status (36)

Country Link
US (1) US7928223B2 (sr)
EP (1) EP2135861B2 (sr)
JP (1) JP5216697B2 (sr)
KR (1) KR101119296B1 (sr)
CN (1) CN101607939B (sr)
AR (1) AR072175A1 (sr)
AU (1) AU2009202314B2 (sr)
BR (1) BRPI0902105A2 (sr)
CA (1) CA2668524C (sr)
CL (1) CL2009001414A1 (sr)
CY (1) CY1115623T1 (sr)
DK (1) DK2135861T4 (sr)
EA (1) EA017333B1 (sr)
ES (1) ES2522625T5 (sr)
FR (1) FR2932800B1 (sr)
GE (1) GEP20125407B (sr)
HK (1) HK1140188A1 (sr)
HR (1) HRP20140928T4 (sr)
JO (1) JO3806B1 (sr)
MA (1) MA31071B1 (sr)
ME (1) ME00814B (sr)
MX (1) MX2009006288A (sr)
MY (1) MY146245A (sr)
NZ (1) NZ577540A (sr)
PE (1) PE20100051A1 (sr)
PL (1) PL2135861T5 (sr)
PT (1) PT2135861E (sr)
RS (1) RS53495B2 (sr)
SA (1) SA109300396B1 (sr)
SG (1) SG158026A1 (sr)
SI (1) SI2135861T2 (sr)
TW (1) TWI374134B (sr)
UA (1) UA107779C2 (sr)
UY (1) UY31883A (sr)
WO (1) WO2009153461A2 (sr)
ZA (1) ZA200904316B (sr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2471780E (pt) * 2007-05-30 2015-02-24 Ind Swift Lab Ltd Sais oxalato de ivabradina cristalinos e seus polimorfos
CN101774969B (zh) * 2009-01-13 2012-07-04 江苏恒瑞医药股份有限公司 硫酸伊伐布雷定及其i型结晶的制备方法
EP2534135A2 (en) 2010-02-12 2012-12-19 KRKA, D.D., Novo Mesto Novel forms of ivabradine hydrochloride
FR2956401B1 (fr) 2010-02-17 2012-02-03 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
WO2011104723A2 (en) * 2010-02-23 2011-09-01 Ind-Swift Laboratories Limited Acid addition salts of ivabradine and preparation thereof
HUP1000245A2 (en) * 2010-05-07 2011-11-28 Richter Gedeon Nyrt Industrial process for the production ivabradin salts
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR3003859B1 (fr) * 2013-03-26 2015-03-13 Servier Lab "procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine"
HU230826B1 (hu) * 2014-11-19 2018-07-30 Richter Gedeon Nyrt. Eljárás benzazepin származékok előállítására
EP3101010A1 (en) 2015-06-03 2016-12-07 Urquima S.A. New method for the preparation of highly pure ivabradine base and salts thereof
CN108424389A (zh) * 2017-02-13 2018-08-21 浙江京新药业股份有限公司 一种伊伐布雷定杂质的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4490369A (en) * 1981-05-19 1984-12-25 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Benzazepine derivatives, their pharmaceutical compositions and method of use
IL70854A0 (en) * 1983-02-04 1984-05-31 Lilly Co Eli Improvements in or relating to benzazepine derivatives
DE3343801A1 (de) * 1983-12-03 1985-06-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue indolderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3418271A1 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3418270A1 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0204349A3 (de) * 1985-06-01 1990-01-03 Dr. Karl Thomae GmbH Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
UA77165C2 (en) * 2000-11-17 2006-11-15 Lilly Co Eli (n)-((s)-2-hydroxy-3-methyl-butyryl)-1-(l-alaninyl)-(s)-1-amino-3-methyl-4,5,6,7-tetrahydro-2h-3-benzazepin-2-one dihydrate, processes for manufacturing and pharmaceutical composition
JPWO2002074746A1 (ja) * 2001-03-16 2004-07-08 山之内製薬株式会社 ベンゾアゼピン誘導体
DE602004017206D1 (de) * 2003-10-23 2008-11-27 Hoffmann La Roche Benzazepin-derivate als mao-b-hemmer
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
KR101589551B1 (ko) * 2005-07-15 2016-02-02 알바니 몰레큘라 리써치, 인크. 아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도

Also Published As

Publication number Publication date
GEP20125407B (en) 2012-02-27
AR072175A1 (es) 2010-08-11
TWI374134B (en) 2012-10-11
EP2135861A1 (fr) 2009-12-23
PL2135861T3 (pl) 2014-11-28
TW201002671A (en) 2010-01-16
ES2522625T3 (es) 2014-11-17
WO2009153461A3 (fr) 2010-04-29
SI2135861T1 (sl) 2014-10-30
MA31071B1 (fr) 2010-01-04
SG158026A1 (en) 2010-01-29
DK2135861T4 (da) 2021-03-22
US20090318682A1 (en) 2009-12-24
BRPI0902105A2 (pt) 2010-04-13
DK2135861T3 (da) 2014-10-20
JO3806B1 (ar) 2021-01-31
CY1115623T1 (el) 2017-01-04
CA2668524A1 (fr) 2009-12-20
UA107779C2 (en) 2015-02-25
HK1140188A1 (en) 2010-10-08
FR2932800A1 (fr) 2009-12-25
EA200900707A1 (ru) 2010-04-30
FR2932800B1 (fr) 2015-02-20
JP5216697B2 (ja) 2013-06-19
AU2009202314B2 (en) 2013-01-24
CL2009001414A1 (es) 2010-06-04
SI2135861T2 (sl) 2021-04-30
PE20100051A1 (es) 2010-02-06
WO2009153461A2 (fr) 2009-12-23
EP2135861B2 (fr) 2020-12-16
HRP20140928T4 (hr) 2021-03-05
HRP20140928T1 (en) 2014-11-21
PT2135861E (pt) 2014-09-02
ME00814B (me) 2012-03-20
RS53495B1 (sr) 2015-02-27
KR20090132544A (ko) 2009-12-30
US7928223B2 (en) 2011-04-19
EP2135861B1 (fr) 2014-07-30
ZA200904316B (en) 2010-05-26
ES2522625T5 (es) 2021-07-29
KR101119296B1 (ko) 2012-03-15
PL2135861T5 (pl) 2022-07-18
JP2010006807A (ja) 2010-01-14
MY146245A (en) 2012-07-31
NZ577540A (en) 2010-10-29
CN101607939B (zh) 2012-05-02
SA109300396B1 (ar) 2013-09-08
CN101607939A (zh) 2009-12-23
AU2009202314A1 (en) 2010-01-14
MX2009006288A (es) 2010-02-17
CA2668524C (fr) 2012-09-11
UY31883A (es) 2010-01-29
EA017333B1 (ru) 2012-11-30

Similar Documents

Publication Publication Date Title
HRP20140928T1 (en) Process for the synthesis of the 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one, and its application to the synthesis of ivabradine as well as its addition salts with a pharmaceutically acceptable acid
HK1145833A1 (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
HK1140186A1 (en) New process for the preparation of functionalised benzocyclobutenes, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
ZA201105172B (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
PL2241553T3 (pl) Sposób syntezy iwabradyny i jej soli addycyjnych z kwasem dopuszczalnym farmaceutycznie
ZA201201329B (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
HK1169827A1 (en) Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
HK1183488A1 (en) Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MD4375C1 (ro) Procedeu de sinteză enzimatică a (7S)-1-(3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-il)-N-metil-metanaminei şi aplicarea în sinteza ivabradinei şi a sărurilor sale
SG165255A1 (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid